ES490848A0 - Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina - Google Patents

Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina

Info

Publication number
ES490848A0
ES490848A0 ES490848A ES490848A ES490848A0 ES 490848 A0 ES490848 A0 ES 490848A0 ES 490848 A ES490848 A ES 490848A ES 490848 A ES490848 A ES 490848A ES 490848 A0 ES490848 A0 ES 490848A0
Authority
ES
Spain
Prior art keywords
bencilcan
cyclodextrin
smoke
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES490848A
Other languages
English (en)
Other versions
ES8103972A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5216479A external-priority patent/JPS55143911A/ja
Priority claimed from JP15715179A external-priority patent/JPS5679650A/ja
Priority claimed from JP920180A external-priority patent/JPS55143912A/ja
Priority claimed from JP1704280A external-priority patent/JPS56113712A/ja
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of ES490848A0 publication Critical patent/ES490848A0/es
Publication of ES8103972A1 publication Critical patent/ES8103972A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES490848A 1979-04-26 1980-04-24 Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina Expired ES8103972A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5216479A JPS55143911A (en) 1979-04-26 1979-04-26 Bencyclane fumarate preparation
JP15715179A JPS5679650A (en) 1979-12-04 1979-12-04 Bencyclane fumarate clathrate compound
JP920180A JPS55143912A (en) 1980-01-28 1980-01-28 Useful preparation comprising bencyclane fumarate
JP1704280A JPS56113712A (en) 1980-02-13 1980-02-13 Production of pharmaceutical preparation of bencyclane fumarate

Publications (2)

Publication Number Publication Date
ES490848A0 true ES490848A0 (es) 1981-04-16
ES8103972A1 ES8103972A1 (es) 1981-04-16

Family

ID=27455119

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490848A Expired ES8103972A1 (es) 1979-04-26 1980-04-24 Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina

Country Status (7)

Country Link
US (1) US4352793A (es)
EP (1) EP0018773B1 (es)
CA (1) CA1146545A (es)
DE (1) DE3063842D1 (es)
ES (1) ES8103972A1 (es)
HU (1) HU183129B (es)
MX (1) MX5999E (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5830032B2 (ja) * 1981-02-18 1983-06-27 呉羽化学工業株式会社 ビフイダス菌の増殖剤
HU183430B (en) * 1981-05-12 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride
DE3372705D1 (en) * 1982-04-30 1987-09-03 Takeda Chemical Industries Ltd Pharmaceutical composition and its use
JPS6140298A (ja) * 1984-06-30 1986-02-26 Zeria Shinyaku Kogyo Kk シクロアルテノ−ルフエルラ酸エステル−シクロデキストリン複合体
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5007966A (en) * 1988-09-21 1991-04-16 American Maize-Products Company Cyclodextrin complexing method
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
US20040014695A1 (en) * 1992-06-19 2004-01-22 Supergen, Inc. Pharmaceutical formulation
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
US20070009532A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
US20070010487A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010485A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010478A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
US20070010486A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE895769C (de) * 1951-08-26 1953-11-05 Knoll Ag Verfahren zur Herstellung von Einschlussverbindungen physiologisch wirksamer organischer Verbindungen
HU179141B (es) * 1977-09-23 1982-08-28
HU176215B (en) * 1978-01-27 1981-01-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1

Also Published As

Publication number Publication date
US4352793A (en) 1982-10-05
EP0018773B1 (en) 1983-06-22
EP0018773A1 (en) 1980-11-12
ES8103972A1 (es) 1981-04-16
DE3063842D1 (en) 1983-07-28
MX5999E (es) 1984-09-18
HU183129B (en) 1984-04-28
CA1146545A (en) 1983-05-17

Similar Documents

Publication Publication Date Title
ES490848A0 (es) Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina
MX9203368A (es) Muramilpeptidos lipofilicos y composiciones farmaceuticas que los contienen.
AR223667A1 (es) Procedimiento para preparar una composicion farmaceutica,con propiedades de almacenamiento y absorcion mejoradas
AR230178A1 (es) Procedimiento para preparar composiciones farmaceuticas
ES491475A0 (es) Un procedimiento para preparar una composicion oral antibac-teriana que contiene un agente de amonio cuaternario y una sal de peroxidifosfato
IT1143089B (it) Procedimento per preparare composizioni farmaceutiche attivate
FI800910A (fi) Farmaceutiskt anvaendbara 4-amino-3-kinolinkarboxylsyror och -estrar
ES487488A0 (es) Procedimiento para preparar una composicion oral que com- prende un compuesto de 2-penem
ES497403A0 (es) Procedimiento para preparar una composicion estable de s- adenosil-l-metionina
IT8147537A0 (it) Composizione farmaceutica a cessione prolungata e procedimento per prepararla
AR230616A1 (es) Esteres de colofonia modificados,procedimiento para su preparacion y composiciones que los contienen
MX150148A (es) Mejoras a envase profilactico para soluciones medicinales
DE3062037D1 (en) 2-(4-aminobutoxy)stilbenes and pharmaceutical compositions comprising these compounds
ES492810A0 (es) Procedimiento para preparar una composicion de resina reso- lica de fenol-formaldehido
AR240018A1 (es) Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
ES492628A0 (es) Un procedimiento para la obtencion de una resina de petroleomodificada
ES491831A0 (es) Un procedimiento para la preparacion de una composicion de fundicion
ES254688Y (es) Una boquilla para fumador
AR228255A1 (es) Procedimiento para la produccion de una preparacion sinergistica que tiene una actividad analgesica y miotonolitica mejorada
AR230571A1 (es) Procedimiento para preparar una composicion farmaceutica
AR230953A1 (es) Procedimiento para preparar una nueva combinacion de farmacos
AR224787A1 (es) 4-alcoxi-n-dimetilamonio-neopentil-naftalimidas,procedimiento para su preparacion y composiciones que las contienen
ES491328A0 (es) Un procedimiento para preparar una composicion de pintura que contiene grupos carboxilatos
AR230929A1 (es) Una composicion saborizante y/o aromatizante y un procedimiento para preparar dicha composicion
SE446535B (sv) 7alfa-metoxicefalosporinderivat och forfarande for framstellning derav samt farmaceutisk komposition derav